M. Markman
Department of Hematology/Medical Oncology
The Cleveland Clinic Foundation
OH 44195
USA
Name/email consistency: high
- Ninety-six-hour infusional paclitaxel as salvage therapy of ovarian cancer patients previously failing treatment with 3-hour or 24-hour paclitaxel infusion regimens. Markman, M., Rose, P.G., Jones, E., Horowitz, I.R., Kennedy, A., Webster, K., Belinson, J., Fusco, N., Fluellen, L., Kulp, B., Peterson, G., McGuire, W.P. J. Clin. Oncol. (1998)
- Paclitaxel administration to gynecologic cancer patients with major cardiac risk factors. Markman, M., Kennedy, A., Webster, K., Kulp, B., Peterson, G., Belinson, J. J. Clin. Oncol. (1998)